Open original FDA record ↗Recall record
- FDA identifier
- Z-0089-2013
- Company in FDA record
- Osteotech Inc
- FDA classification date
- Oct 18, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
Multiple lots of GRAFTON and XPANSE , which are used for bone grafting procedures are being recalled because there is a possibility that sterility of the outer surface of the inner pouch may become compromised.
Source facts
- Action
- Osteotech sent out recall letters/questionairres dated April 20, 2012, to Risk Managers/service representatives. The recall was expanded on August 1 2012. The letter identified the product, the problem, and the action to be taken by the customer. Sales Representatives would facillitate the return of any affected product they may have or provide cautionary labels for any affected product and/or support in the completion of the attached questionnaire. Customers were asked to disseminate this information to additional personnel within their facility as appropriate and return the questionnaire to Medtronic.. Customers with questions should contact their Medtronic Sales Representative at 800-876-3133, extension 3197. For questions regarding this recall call 732-542-2800. Osteotech sent an additional letter stating that The OPTIUMTM (DBM) product line was added in error.
- Initiated
- 2012-04-20
- Root cause
- Device Design
- Terminated
- 2014-01-17
- Distribution
- Worldwide Distribution - USA (nationwide) and Internationally.
- Recall number
- Z-0089-2013
- Recall status
- Terminated
- CDRH record ID
- 112937
- FDA classified
- 2012-10-18
- Recall event number
- 62569